DUBLIN–(BUSINESS WIRE)–The “Intravenous (IV) Solutions – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Intravenous (IV) Solutions Market to Reach $16 Billion by 2027
Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$11 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 8.4% CAGR
The Intravenous (IV) Solutions market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.4% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.
Select Competitors (Total 67 Featured)
Amanta Healthcare
Anhui Medipharm Co., LTD.
Axa Parenterals Ltd.
B. Braun Melsungen Ag
Baxter International Inc.
Fresenius Kabi AG
Grifols, S.A.
ICU Medical, Inc.
JW Life Science
Otsuka Pharmaceutical Co. Ltd.
Pfizer Inc.
Salius Pharma Private Limited.
Vifor Pharma Management Ltd.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
Rising Cancer Incidence and Need for Nutritional Support
Alarming Rise in Diabetes Incidence Worldwide
Unrelenting Threat of HIV/AIDS Infection
Nutritional Management of Patients with Neurological Diseases
Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
Growing Numbers of Pre-term Births Drives Demand for IV Solutions
Demand Rises for Home Intravenous Nutritional Therapies
Premixed IV Nutrition: A Step towards Safer Medication Practices
Premixed Formulations Present Efficient Delivery System
Iron Replacement Therapies: Potential for Growth
Growing Demand for Low-Cost Intravenous Nutrition Solutions
COVID-19 Outbreak: Combating Medication Errors in IV Infusion
Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
Increasing Healthcare Expenditure Creates Conducive Environment
Challenges Confronting IV Solutions Market
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/xgvpe0
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
